Insider Transactions in Q4 2022 at Myovant Sciences Ltd. (MYOV)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 16
2022
|
Uneek Mehra Principal Financial Officer |
SELL
Open market or private sale
|
Direct |
2,241
-1.09%
|
$58,266
$26.75 P/Share
|
|
Oct 26
2022
|
Nancy Valente Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,859
+50.0%
|
-
|
|
Oct 26
2022
|
Myrtle S Potter Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,859
+50.0%
|
-
|
|
Oct 26
2022
|
Adele M. Gulfo Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,859
+50.0%
|
-
|
|
Oct 26
2022
|
Mark Guinan Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,859
+50.0%
|
-
|
|
Oct 26
2022
|
Terrie Curran Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,859
+50.0%
|
-
|
|
Oct 18
2022
|
Lauren Merendino Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
1,703
-0.98%
|
$42,575
$25.2 P/Share
|
|
Oct 18
2022
|
David C Marek Principal Executive Officer |
SELL
Open market or private sale
|
Direct |
11,156
-2.55%
|
$278,900
$25.2 P/Share
|
|
Oct 18
2022
|
Matthew Lang General Counsel & Corp. Secy. |
SELL
Open market or private sale
|
Direct |
1,933
-0.54%
|
$48,325
$25.2 P/Share
|
|
Oct 18
2022
|
Ferreira Juan Camilo Arjona Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,604
-0.64%
|
$40,100
$25.2 P/Share
|
|
Oct 04
2022
|
Matthew Lang General Counsel & Corp. Secy. |
SELL
Open market or private sale
|
Direct |
3,679
-1.01%
|
$88,296
$24.4 P/Share
|
|
Oct 04
2022
|
Ferreira Juan Camilo Arjona Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,738
-1.08%
|
$65,712
$24.4 P/Share
|